Analysis
195 companies joined Crunchbase's Unicorn Board in the first half of 2026 alone -- already more than the 193 that reached billion-dollar valuations across all of 2025, according to Crunchbase News. It's the fastest pace of new-unicorn creation since the second half of 2022.
Robotics and AI "neolabs" led the cohort, with financial services, healthcare and biotech, AI infrastructure and deployment tooling, defense, semiconductors and aerospace also producing meaningful numbers of new billion-dollar companies. The most valuable single addition was China-based open-source model developer DeepSeek, valued at $50 billion in its first external financing round -- a striking figure for a company that entered the year known mainly for a free, open-weight model rather than a funded startup.
The concentration at the top of the cohort:
“The concentration at the top of the cohort: - Decacorns ($10B+) -- 4 companies crossed the threshold in H1 2026.”
- Decacorns ($10B+) -- 4 companies crossed the threshold in H1 2026.
- $5B+ unicorns -- 5 more companies cleared that mark.
- Global VC funding, H1 2026 -- a record $510 billion, already surpassing the $440 billion invested across all of 2025.
That concentration at the top mirrors what's happening in overall venture funding.
The pace says less about broad-based startup health than about how much capital is chasing a narrow set of categories. AI infrastructure, chips and robotics are pulling disproportionate dollars into fewer, larger rounds -- the same dynamic that's produced mega-financings like Nvidia's $500 billion Wall Street push and OpenAI's $122 billion round this year. For early-stage investors outside those categories, the unicorn count is a reminder that capital concentration at the top isn't loosening even as the headline numbers look broad and healthy.
